153 related articles for article (PubMed ID: 35773149)
1. Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88.
Ljungberg B; Bedke J; Capitanio U; Bex A
Eur Urol; 2022 Oct; 82(4):e111-e112. PubMed ID: 35773149
[No Abstract] [Full Text] [Related]
2. Re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.006.
Wei Y; Zhang R; Lin L
Eur Urol; 2022 Sep; 82(3):e88. PubMed ID: 35750581
[No Abstract] [Full Text] [Related]
3. Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li's Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3-5.
Capitanio U; Bedke J; Albiges L; Volpe A; Giles RH; Hora M; Marconi L; Klatte T; Abu-Ghanem Y; Dabestani S; Fernández Pello S; Hofmann F; Kuusk T; Campi R; Tahbaz R; Powles T; Ljungberg B; Bex A
Eur Urol; 2023 Mar; 83(3):e74-e75. PubMed ID: 36526491
[No Abstract] [Full Text] [Related]
4. Re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2023;83:3-5.
Tang Y; Hu X; Wu K; Shao Y; Li X
Eur Urol; 2023 Mar; 83(3):e73. PubMed ID: 36526493
[No Abstract] [Full Text] [Related]
5. Re: Laurence Albiges, Tom Powles, Michael Staehler, et al. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-Cell Renal Cell Carcinoma. Eur Urol 2019;76:151-6: Active Surveillance in Metastatic Renal Cell Cancer: Missing a Chance for Cure?
de Joode K; van der Veldt AAM
Eur Urol; 2020 Mar; 77(3):e76-e77. PubMed ID: 31610901
[No Abstract] [Full Text] [Related]
6. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80:e100: Reply from the European Association of Urology Equity, Diversity, and Inclusion Task Force.
Carmen Mir M; Greenwell T; O'Kelly F; Proietti S; Laukhtina E; Mertens L; Morgenstern S; Ouzaid I;
Eur Urol; 2022 Jan; 81(1):e26-e27. PubMed ID: 34772550
[No Abstract] [Full Text] [Related]
7. Reply to Yan Shibing and Wei Qiang's Letter to the Editor re: Morgan Rouprêt, Marko Babjuk, Eva Compérat, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 2015;68:868-79.
Rouprêt M
Eur Urol; 2016 Mar; 69(3):e51-2. PubMed ID: 26461109
[No Abstract] [Full Text] [Related]
8. Reply to Lorenzo Marconi, Karim Bensalah, and Axel Bex's Letter to the Editor re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019;76:136-7.
Verhagen PCMS; Boevé ER
Eur Urol; 2019 Jul; 76(1):e14. PubMed ID: 30910344
[No Abstract] [Full Text] [Related]
9. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80:e100.
Dev S
Eur Urol; 2022 Jan; 81(1):e25. PubMed ID: 34663524
[No Abstract] [Full Text] [Related]
10. Re: Nizar M. Tannir, Eric Jonasch, Laurence Albiges, et al. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN):A Randomized Multicenter Phase 2 Trial. Eur Urol 2016;69:866-74.
Yang Z; Qi L; Chen M
Eur Urol; 2017 Jan; 71(1):e23-e24. PubMed ID: 27344295
[No Abstract] [Full Text] [Related]
11. Reply to Takeshi Takahashi's Letter to the Editor re: Riccardo Campi, Riccardo Bertolo, Andrea Minervini, European Association of Urology Young Academic Urologists Renal Cancer Working Group. Re: Partial Versus Radical Nephrectomy in Clinical T2 Renal Masses. Klett DE, Tsivian M, Packiam VT, et al. Int J Urol. 2021;28:1149-54. Eur Urol 2021;80;760-2. Partial Nephrectomy for T2 Kidney Cancer Might Violate the Declaration of Helsinki: Re-envisioning the Value of Clinical Research to Foster the Progress of Evidence-based Urology: The Case of Partial Nephrectomy for cT2 Renal Masses.
Campi R; Bertolo R; Minervini A;
Eur Urol; 2022 Feb; 81(2):e46-e47. PubMed ID: 34887115
[No Abstract] [Full Text] [Related]
12. Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End.
Massari F; Di Nunno V; Santoni M; Gatto L; Mollica V; Porta C
Eur Urol Oncol; 2019 Sep; 2(5):603-604. PubMed ID: 31411982
[No Abstract] [Full Text] [Related]
13. Re: Anders Lidgren, Ylva Hedberg, Kjell Grankvist, Torgny Rasmuson, Anders Bergh and Börje Ljungberg. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray. Eur Urol 2006;50:1272-7.
Minervini A; Di Cristofano C; Serni S; Carini M
Eur Urol; 2007 May; 51(5):1451-2; author reply 1452-3. PubMed ID: 17239525
[No Abstract] [Full Text] [Related]
14. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yuen-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9.
Teoh JY; Murphy DG; van Oort IM; Loeb S; Ribal MJ
Eur Urol; 2021 Oct; 80(4):e101. PubMed ID: 34315625
[No Abstract] [Full Text] [Related]
15. Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albigès, et al. Cabazitaxel remains active in patients progressing after docetaxel followed by novel androgen receptor pathway targeted therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015.
van Soest RJ; de Wit R; van Weerden WM
Eur Urol; 2014 Oct; 66(4):e71-2. PubMed ID: 25012524
[No Abstract] [Full Text] [Related]
16. Reply to Ping Zhong, Xin Liu, and Limin Liao's Letter to the Editor re: Michele Gnech, Lisette 't Hoen, Alexandra Zachou, et al. Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.12.005.
Gnech M; 't Hoen L; Burgu B; Radmayr C
Eur Urol; 2024 May; ():. PubMed ID: 38735821
[No Abstract] [Full Text] [Related]
17. Re: Börje Ljungberg, Damian C. Hanbury, Marcus A. Kuczyk, Axel S. Merseburger, Peter F.A. Mulders, Jean-Jaques Patard and Ioanel C. Sinescu. Renal cell cacinoma guideline. Eur Urol 2007;51:1502-10.
Di Lorenzo G
Eur Urol; 2007 Sep; 52(3):926-8; author reply 928. PubMed ID: 17574728
[No Abstract] [Full Text] [Related]
18. Reply to Takeshi Takahashi's Letter to the Editor re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting functional outcomes after partial and radical nephrectomy. Eur Urol 2019;75:766-72. Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
Bhindi B; Lohse CM; Schulte PJ; Mason RJ; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Sep; 76(3):e67-e68. PubMed ID: 31167750
[No Abstract] [Full Text] [Related]
19. Reply to Fabian Falkenbach, Francesco Sanguedolce, and Lars Budäus's Letter to the Editor re: Elie Kaplan-Marans, Tenny R. Zhang, Jim C. Hu. Differing Recommendations on Prostate Biopsy Approach to Minimize Infections: An Examination of the European Association of Urology and American Urological Association Guidelines. Eur Urol. 2023;84:445-46.
Kaplan-Marans E; Zhang TR; Hu JC
Eur Urol; 2023 Dec; 84(6):e151. PubMed ID: 37775359
[No Abstract] [Full Text] [Related]
20. Reply to Meny Lv, Xufei Luo, and Yaolong Chen's Letter to the Editor re: Mauro Gacci, Vasileios I. Sakalis, Markos Karavitakis, et al. European Association of Urology Guidelines on Male Urinary Incontinence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.012.
Gacci M; Sakalis VI; Karavitakis M; Gravas S
Eur Urol; 2022 Oct; 82(4):e119-e120. PubMed ID: 35945088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
